NCT03191773 2017-06-20A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell MalignanciesSecond Affiliated Hospital of Guangzhou Medical UniversityPhase 1/2 Unknown100 enrolled